drugset / Trial / NCT05198128

Ovarian Hyperstimulation Syndrome Using Calcium Infusion

NCT05198128

Unknown 200 enrolled Al-Azhar University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

the incidence of OHSS and clinical outcomes after calcium IV infusion in high-risk women undergoing ART

Timeline

Start
2022-03-01
Primary completion
2023-04-25
Completion
2023-05-10

Drugs

EvaluationDrugModalityDoseRoute
Subject calcium gluconate Small molecule 10 ml Intravenous